James W. Mccollum - 13 May 2024 Form 4 Insider Report for LENZ Therapeutics, Inc. (LENZ)

Role
Director
Signature
/s/ Evert Schimmelpennink, as Attorney-in-Fact
Issuer symbol
LENZ
Transactions as of
13 May 2024
Net transactions value
+$501,093
Form type
4
Filing time
14 May 2024, 17:29:43 UTC
Previous filing
25 Mar 2024
Next filing
11 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LENZ Common Stock Purchase $501,093 +31,332 +6.3% $15.99* 525,565 13 May 2024 By trust F1
holding LENZ Common Stock 95,034 13 May 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 31,332 shares purchased in the price range of $15.96 to $16.00 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.